These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17488408)

  • 21. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease.
    Bagazgoitia L; Cuevas J; Juarranz A
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
    Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
    Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The characteristics of human papillomavirus expression and cell proliferation in actinic keratosis and Bowen's disease of the skin.
    Kvlividze O; Gogiashvili L; Burkadze G
    Georgian Med News; 2006 Jul; (136):108-12. PubMed ID: 16905862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for field cancerisation treatment of actinic keratoses with topical diclofenac in hyaluronic acid.
    Ulrich M; Pellacani G; Ferrandiz C; Lear JT
    Eur J Dermatol; 2014; 24(2):158-67. PubMed ID: 24721544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients.
    Salleras Redonnet M; Quintana Codina M
    Dermatol Ther; 2016 Jul; 29(4):236-9. PubMed ID: 26969886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

  • 29. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
    Sidoroff A; Thaler P
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis, Bowen's Disease, and Squamous Cell Carcinoma: A Systematic Review.
    Lapidus AH; Lee S; Liu ZF; Smithson S; Chew CY; Gin D
    J Cutan Med Surg; 2024; 28(4):375-380. PubMed ID: 38783539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bowenoid Actinic Keratosis and Bowen's Disease Treated Successfully with Ingenol Mebutate.
    Mohanna MT; Hofbauer GF
    Dermatology; 2016; 232 Suppl 1():14-6. PubMed ID: 27513957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
    Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
    J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group.
    Pflugfelder A; Welter AK; Leiter U; Weide B; Held L; Eigentler TK; Dirschka T; Stockfleth E; Nashan D; Garbe C;
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):48-53. PubMed ID: 21414035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
    Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
    Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diclofenac for actinic keratoses: a formulation issue.
    Cox NH
    Clin Exp Dermatol; 2006 Nov; 31(6):819-20. PubMed ID: 16939582
    [No Abstract]   [Full Text] [Related]  

  • 38. Reassessment of topical diclofenac/hyaluronan gel for actinic keratoses.
    Burkhart CN; Burkhart CG
    Int J Dermatol; 2002 Jun; 41(6):371-2. PubMed ID: 12100697
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel.
    Rivers JK; Wolf J
    Acta Derm Venereol; 2007; 87(2):188-9. PubMed ID: 17340038
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):373-9. PubMed ID: 12769404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.